BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.
1 report, 1 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.